Adaptive Biotechnologies Corp
ADPT
42 insider filings · Latest: Apr 27, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 11, 2026 | Mar 17 12:53 AM | PISKEL KYLE | Proposed Sale | 18,672 | $14.52 | $271.1K | — | View → |
| Mar 11, 2026 | Mar 17 12:46 AM | RUBINSTEIN JULIE | Proposed Sale | 122,523 | $14.52 | $1.8M | — | View → |
| Mar 11, 2026 | Mar 17 12:40 AM | ROBINS HARLAN S | Proposed Sale | 470,266 | $14.52 | $6.8M | — | View → |
| Mar 11, 2026 | Mar 17 12:33 AM | ROBINS CHAD M | Proposed Sale | 470,167 | $14.52 | $6.8M | — | View → |
| Mar 13, 2026 | Mar 14 1:36 AM | Julie RubinsteinPresident and COO | Sale | 19,060 | $12.96 | $247.0K | 507,934(D) | View → |
| Mar 12, 2026 | Mar 14 1:36 AM | Julie RubinsteinPresident and COO | Sale | 19,060 | $12.86 | $245.0K | 512,272(D) | View → |
| Mar 11, 2026 | Mar 14 1:36 AM | Julie RubinsteinPresident and COO | Sale | 141,583 | $13.29 | $1.9M | 516,610(D) | View → |
| Mar 11, 2026 | Mar 14 1:05 AM | Michelle Renee GriffinDirector | Sale | 15,394 | $13.91 | $214.1K | 15,625(D) | View → |
| Mar 11, 2026 | Mar 14 1:02 AM | Francis LOChief People Officer | Sale | 30,593 | $14.08 | $430.7K | 291,374(D) | View → |
| Mar 11, 2026 | Mar 14 12:59 AM | Susan BobulskyChief Commercial Officer, MRD | Sale | 41,338 | $13.17 | $544.4K | 427,775(D) | View → |
| Mar 11, 2026 | Mar 14 12:55 AM | Sharon BenzenoChief Commercial Ofc Imm Med | Sale | 63,103 | $13.17 | $831.1K | 272,751(D) | View → |
| Mar 11, 2026 | Mar 14 12:52 AM | Kyle PiskelChief Financial Officer | Sale | 18,672 | $13.17 | $245.9K | 259,840(D) | View → |
| Mar 11, 2026 | Mar 14 12:49 AM | Harlan S RobinsChief Scientific Officer | Sale | 470,266 | $13.17 | $6.2M | 1,522,058(D) | View → |
| Mar 11, 2026 | Mar 14 12:45 AM | Chad M RobinsDirector, CEO and Chairman | Sale | 470,167 | $13.17 | $6.2M | 2,301,113(D) | View → |
| Mar 11, 2026 | Mar 11 8:42 PM | FRANCIS LO | Proposed Sale | 30,593 | $14.52 | $444.2K | — | View → |
| Mar 11, 2026 | Mar 11 8:21 PM | MICHELLE GRIFFIN | Proposed Sale | 15,394 | $13.91 | $214.1K | — | View → |
| Mar 10, 2026 | Mar 11 12:04 AM | Julie RubinsteinPresident and COO | Sale | 19,460 | $14.68 | $285.7K | 643,471(D) | View → |
| Mar 9, 2026 | Mar 11 12:04 AM | Julie RubinsteinPresident and COO | Sale | 30,941 | $14.79 | $457.6K | 647,809(D) | View → |
| Mar 6, 2026 | Mar 11 12:04 AM | Julie RubinsteinPresident and COO | Sale | 30,941 | $15.14 | $468.4K | 652,147(D) | View → |
| Mar 5, 2026 | Mar 10 11:53 PM | LO FRANCIS | Proposed Sale | 38,074 | $16.44 | $625.9K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 3, 2026 | Mar 6 12:42 AM | Julie RubinsteinPresident and COO | Option Exercise | 26,603 | $12.14 | 451,463(D) | View → |
| Feb 4, 2026 | Feb 7 12:30 AM | Kyle PiskelChief Financial Officer | Option Exercise | 2,145 | $12.14 | 2,146(D) | View → |
← Previous
Page 3 of 3